VolitionRx Files 8-K for Regulation FD Disclosure

Ticker: VNRX · Form: 8-K · Filed: Apr 4, 2025 · CIK: 93314

Sentiment: neutral

Topics: disclosure, regulation-fd

Related Tickers: VNRX

TL;DR

VNRX filed an 8-K for a Reg FD disclosure, no other details yet.

AI Summary

VolitionRx Limited filed an 8-K on April 4, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or material events beyond the disclosure itself. The company, previously known as Standard Capital Corp, is incorporated in Delaware and headquartered in Henderson, Nevada.

Why It Matters

This filing indicates VolitionRx is making a disclosure under Regulation FD, which ensures all investors receive important information simultaneously. The specific nature of the disclosure is not detailed in this summary.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure and does not contain information about significant financial changes, operational risks, or market-moving events.

Key Players & Entities

FAQ

What is the specific nature of the Regulation FD Disclosure being made by VolitionRx Limited?

The provided filing summary does not specify the exact content of the Regulation FD Disclosure.

When was VolitionRx Limited incorporated?

VolitionRx Limited was incorporated in Delaware.

What is the principal executive office address for VolitionRx Limited?

The principal executive offices are located at 1489 West Warm Springs Road, Suite 110, Henderson, Nevada 89014.

What was VolitionRx Limited's former company name?

VolitionRx Limited was formerly known as Standard Capital Corp.

What is the Commission File Number for VolitionRx Limited?

The Commission File Number for VolitionRx Limited is 001-36833.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 4, 2025 regarding VOLITIONRX LTD (VNRX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing